EFFICACY AND SAFETY OF SINGLE STAGE ENDOVASCULAR INTERVENTIONS WITH TRANSCATHETER IMPLANTING OF AORTIC VALVE
https://doi.org/10.15829/1560-4071-2016-11-41-46
Abstract
Transcatheter implanting of aortic valve (TIAV) in critical aortic stenosis is a separate manipulation requiring thorough preparation. Among patients with critical aortic stenosis from a group of endovascular correction, there is a high prevalence of comorbid atherosclerotic lesions in coronary, carotid arteries, and other pathologies, manageable only interventionally.
Aim. To assess the efficacy and safety of single-moment performing of TIAV and additional endovascular interventions.
Material and methods. From the year 2011, in our clinic endovascular implanting of aortic valve was done for 125 patients with aortic valve dysfunction, in 51% (64 patients) had coronary, renal and carotid arteries lesion, aneurysmatic dilation of abdominal aorta. In 31 (48%) cases together with endovascular valve placement additionally endovascular interventions were done.
Results. Technical success was reached in all 125 cases. In-patient mortality from all causes was 7.2% (9 patients), with no significant difference between combination treatment group and other patients. In 2 cases there was stenting done, of coronary and carotid arteries (with 1 case of coronary, carotid and renal arteries), as single step. In one patient there was endovascular prevention done of ischemic complications of permanent atrial fibrillation by implanting of the system Watchman (Boston Scientific, USA) and stenting of coronary arteries; in one case a single step endoprosthesing of abdominal aorta was done and coronary stenting. In concomitant interventions group there was no myocardial infarction and no significant difference in cerebrovascular events between groups.
Conclusion. TIAV can be followed by single step addition of endovascular procedures if the surgical team and clinics has good experience, and with thorough planning of operation and post-surgery period.
About the Authors
K. V. KochkinaRussian Federation
T. A. Kochkina
Russian Federation
O. B. Mashtakova
Russian Federation
G. A. Usik
Russian Federation
A. V. Myznikov
Russian Federation
F. S. Kulakov
Russian Federation
D. A. Malyshkin
Russian Federation
A. V. Sidorenko
Russian Federation
S. E. Evtyagin
Russian Federation
A. V. Protopopov
Russian Federation
References
1. Singh IM, Shishehbor MH, Christofferson RD, et al. Percutaneous treatment of aortic valve stenosis. Clevel Clin J Med 2008 (11): 805-12.
2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a populationbased study. Lancet 2006; 368: 1005-11.
3. Paradis JM, Fried J, Nazif T, et al. Aortic stenosis and coronary artery disease: What do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms. European Heart Journal 2014; 35: 2069-82.
4. Steinvil A, Sadeh B, Arbel Y, et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol. 2011; 57: 779-83.
5. Elkalioubie А, Jude B, Dupont A. Abdominal aortic aneurysm in patients with coronary artery disease: a review article. In Diagnosis and Treatment of Abdominal and Thoracic Aortic Aneurysms Including the Ascending Aorta and the Aortic Arch, R. Grundmann, Ed., 2011: 71-88.
6. Ramanath VS, Oh JK, Sundt TM, et al. Acute Aortic Syndromes and Thoracic Aortic Aneurysm. Mayo Clinic Proceedings. 2009; 84(5): 465-81.
7. Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-5.
8. Bach DS, Siao D, Girard SE, et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement. Circ Cardiovasc Qual Outcomes 2009; 2: 533-9.
9. Imaev TE, Komlev AE, Saidova MA, et al. 5-year experience with transcatheter aortic bioprosthetic valve implantation in Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation. Consilium medicum. 2015; 17(10): 67-72. Russian (Имаев Т. Э., Комлев А. Е., Саидова М. А., Марголина А. А., Акчурин Р. С. Пятилетний опыт транскатетерной имплантации биопротезов аортального клапана в ФГБУ Российский кардиологический научно-производственный комплекс Минздрава России. Consilium medicum. 2015; 17(10): 67-72).
10. Kochkina KV, Shtark AA, Protopopov AV. Endovascular treatment of severe aortic stenosis in high and intermediate surgical risks patients. Heart and Blood Vessels. Journal of the Cardiology Society of Serbia. 2015; 34(1): 24-8.
11. Drury-Smith M, Garnham A, Khogali S. Critical aortic stenosis in a patient with a large saccular abdominal aortic aneurysm: simultaneous transcatheter aortic valve implantation and drive-by endovascular aortic aneurysm repair. Catheter Cardiovasc Interv. 2012 Nov 15; 80(6): 1014-8.
12. Marchi F, Cerillo AG, Rizza A, et al. Large Abdominal Aortic Aneurysm in a High-Risk Surgical Patient: Combined Percutaneous Transfemoral TAVI and EVAR Procedure. J Heart Valve Dis. 2015; 24(3): 310-2.
Review
For citations:
Kochkina K.V., Kochkina T.A., Mashtakova O.B., Usik G.A., Myznikov A.V., Kulakov F.S., Malyshkin D.A., Sidorenko A.V., Evtyagin S.E., Protopopov A.V. EFFICACY AND SAFETY OF SINGLE STAGE ENDOVASCULAR INTERVENTIONS WITH TRANSCATHETER IMPLANTING OF AORTIC VALVE. Russian Journal of Cardiology. 2016;(11):41-46. (In Russ.) https://doi.org/10.15829/1560-4071-2016-11-41-46